Rongkuan Hu

Efficacy and safety of an mRNA-based RSV preF vaccine in preclinical studies

This paper evaluates an mRNA-based RSV preF vaccine, STR-V003, showing robust immunogenicity, safety, and protective immunity in preclinical studies, leading to FDA approval for phase I clinical trials.

Immunogenicity of Rabies Virus G-Protein mRNA Formulated with Muscle Targeting Lipid Nanoparticles in Mice

This study evaluates an mRNA vaccine encoding the Rabies Virus G-protein formulated with muscle-targeting lipid nanoparticles, showing high immunogenicity and protection in mice.